Calliditas Therapeutics AB (publ) (CALT)
USD 40.0
(-0.1%)
USD 40.0
(-0.1%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -466.18 Million SEK | -13.08% |
| 2022 | -412.26 Million SEK | 19.09% |
| 2021 | -509.53 Million SEK | -16.73% |
| 2020 | -436.51 Million SEK | -1239.9% |
| 2019 | -32.57 Million SEK | 75.33% |
| 2018 | -132.04 Million SEK | -52.14% |
| 2017 | -86.79 Million SEK | -52.51% |
| 2016 | -56.91 Million SEK | -11.56% |
| 2015 | -51.01 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -246.16 Million SEK | -1240.16% |
| 2024 Q2 | -47.47 Million SEK | 80.71% |
| 2023 Q3 | -168.35 Million SEK | -83.13% |
| 2023 Q4 | -18.36 Million SEK | 89.09% |
| 2023 Q2 | -91.93 Million SEK | 50.98% |
| 2023 Q1 | -187.52 Million SEK | -4994.4% |
| 2023 FY | -466.18 Million SEK | -13.08% |
| 2022 Q1 | -207.04 Million SEK | 5.53% |
| 2022 Q2 | -192.42 Million SEK | 7.06% |
| 2022 FY | -412.26 Million SEK | 19.09% |
| 2022 Q4 | -3.68 Million SEK | 59.59% |
| 2022 Q3 | -9.11 Million SEK | 95.27% |
| 2021 FY | -509.53 Million SEK | -16.73% |
| 2021 Q1 | -125.45 Million SEK | 26.39% |
| 2021 Q4 | -219.17 Million SEK | -3498.51% |
| 2021 Q3 | 6.44 Million SEK | 104.03% |
| 2021 Q2 | -159.84 Million SEK | -27.41% |
| 2020 FY | -436.51 Million SEK | -1239.9% |
| 2020 Q2 | -61.32 Million SEK | 3.75% |
| 2020 Q1 | -63.71 Million SEK | -176.42% |
| 2020 Q3 | -138.02 Million SEK | -125.06% |
| 2020 Q4 | -170.43 Million SEK | -23.48% |
| 2019 Q4 | -23.05 Million SEK | 54.03% |
| 2019 Q2 | 83.16 Million SEK | 295.43% |
| 2019 Q1 | -42.55 Million SEK | 3.77% |
| 2019 FY | -32.57 Million SEK | 75.33% |
| 2019 Q3 | -50.13 Million SEK | -160.29% |
| 2018 Q4 | -44.22 Million SEK | -40.83% |
| 2018 Q3 | -31.4 Million SEK | -72.69% |
| 2018 Q2 | -18.18 Million SEK | 52.44% |
| 2018 Q1 | -38.23 Million SEK | 5.69% |
| 2018 FY | -132.04 Million SEK | -52.14% |
| 2017 Q4 | -40.54 Million SEK | -120.6% |
| 2017 Q2 | -16.11 Million SEK | -37.0% |
| 2017 Q1 | -11.76 Million SEK | 0.0% |
| 2017 FY | -86.79 Million SEK | -52.51% |
| 2017 Q3 | -18.37 Million SEK | -14.08% |
| 2016 FY | -56.91 Million SEK | -11.56% |
| 2015 FY | -51.01 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -49706.09% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -12892.893% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -818716.524% |
| IO Biotech, Inc. | -86.08 Million USD | -441.553% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1416.098% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1630.585% |
| MEI Pharma, Inc. | 17.77 Million USD | 2722.258% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -171.559% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -131.252% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1148.487% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -122.671% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -204.712% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -3466.324% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -106.963% |
| Agenus Inc. | -245.76 Million USD | -89.69% |
| AlloVir, Inc. | -190.41 Million USD | -144.822% |
| CRISPR Therapeutics AG | -153.61 Million USD | -203.486% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -648.831% |
| NextCure, Inc. | -62.72 Million USD | -643.244% |
| Opthea Limited | -220.24 Million USD | -111.669% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -690.376% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1757.977% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1815.36% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -608.865% |
| Senti Biosciences, Inc. | -92.91 Million USD | -401.711% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -797.805% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -4586.338% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -5.893% |
| BioLineRx Ltd. | -60.61 Million USD | -669.104% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -997.061% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -535.588% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1267.071% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -699.727% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -595.85% |
| AbCellera Biologics Inc. | -146.39 Million USD | -218.437% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1550.855% |
| Aptorum Group Limited | -2.82 Million USD | -16404.186% |
| AnaptysBio, Inc. | -163.61 Million USD | -184.921% |
| Ardelyx, Inc. | -66.06 Million USD | -605.625% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -127.103% |
| Bicycle Therapeutics plc | -180.66 Million USD | -158.04% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -160.361% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -251.856% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1335.078% |
| Chimerix, Inc. | -82.09 Million USD | -467.86% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -945.18% |
| Dyadic International, Inc. | -6.79 Million USD | -6760.241% |
| Elevation Oncology, Inc. | -45.7 Million USD | -920.009% |
| ESSA Pharma Inc. | -26.58 Million USD | -1653.739% |
| Fortress Biotech, Inc. | -60.63 Million USD | -668.813% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -189.685% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1163.394% |
| Fortress Biotech, Inc. | -60.63 Million USD | -668.813% |
| ChromaDex Corporation | -4.93 Million USD | -9340.765% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -5842.152% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -374.986% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -356.731% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -312.696% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -93.148% |
| Incyte Corporation | 597.59 Million USD | 178.01% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -245.022% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -4323.847% |
| Jaguar Health, Inc. | -41.3 Million USD | -1028.777% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 212.379% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5383.884% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 993.862% |
| ContextLogic Inc. | -317 Million USD | -47.062% |
| Lantern Pharma Inc. | -15.96 Million USD | -2820.678% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -24.772% |
| MiMedx Group, Inc. | 67.43 Million USD | 791.269% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -229.681% |
| Structure Therapeutics Inc. | -89.62 Million USD | -420.18% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -471.445% |
| Onconetix, Inc. | -37.4 Million USD | -1146.161% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1080.843% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -811.246% |
| PDS Biotechnology Corporation | -42.94 Million USD | -985.61% |
| Precigen, Inc. | -95.9 Million USD | -386.095% |
| Pharming Group N.V. | -10.54 Million USD | -4319.653% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1799.462% |
| PureTech Health plc | -65.69 Million USD | -609.599% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -299.138% |
| Royalty Pharma plc | 1.13 Billion USD | 141.08% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1815.36% |
| Seer, Inc. | -86.27 Million USD | -440.335% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -80.81% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1611.524% |
| Acelyrin, Inc. | -381.64 Million USD | -22.153% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -3716686.431% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -531.773% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2413.656% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -183.268% |
| TG Therapeutics, Inc. | 12.67 Million USD | 3778.859% |
| Alkermes plc | 355.75 Million USD | 231.04% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -6873.598% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -8271.072% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -849.074% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -4568.386% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1487.715% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -710.573% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -119.671% |
| Geron Corporation | -184.12 Million USD | -153.187% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2197.496% |
| Summit Therapeutics Inc. | -614.92 Million USD | 24.189% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -345.262% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1226.651% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2349.881% |
| Innoviva, Inc. | 179.72 Million USD | 359.392% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -756.611% |
| Vaxcyte, Inc. | -402.26 Million USD | -15.89% |
| Molecular Templates, Inc. | -8.12 Million USD | -5638.368% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1538.496% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 18.619% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -813.05% |
| Novavax, Inc. | -545.06 Million USD | 14.471% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1201.793% |
| Scopus BioPharma Inc. | -11.6 Million USD | -3915.435% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 752.829% |
| Precision BioSciences, Inc. | -61.31 Million USD | -660.262% |
| GT Biopharma, Inc. | -7.59 Million USD | -6036.435% |
| ImmuCell Corporation | -5.77 Million USD | -7973.029% |
| Immix Biopharma, Inc. | -15.42 Million USD | -2922.064% |
| Mesoblast Limited | -87.95 Million USD | -430.021% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -89.819% |
| Aptose Biosciences Inc. | -51.2 Million USD | -810.393% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -374.257% |
| Soligenix, Inc. | -6.14 Million USD | -7491.687% |
| Century Therapeutics, Inc. | -136.67 Million USD | -241.095% |
| Kura Oncology, Inc. | -152.63 Million USD | -205.433% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -422.523% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 82542.039% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -81830.58% |
| Autolus Therapeutics plc | -208.38 Million USD | -123.715% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -548.398% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -558.5% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2051.491% |
| GRI Bio, Inc. | -13.03 Million USD | -3475.861% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -11175.274% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -275.701% |
| IGM Biosciences, Inc. | -246.41 Million USD | -89.186% |
| INmune Bio, Inc. | -30 Million USD | -1453.536% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -321.662% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1004.866% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2820.655% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -2851.475% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -681.076% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -360.807% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -68.831% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -95.965% |
| Verastem, Inc. | -87.36 Million USD | -433.594% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -760.31% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -188.953% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -299.617% |
| Histogen Inc. | -10.62 Million USD | -4289.276% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3163.057% |
| Surrozen, Inc. | -43.04 Million USD | -983.093% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3077.595% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -9064.19% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -790.704% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1745.327% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -5478.32% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -208.558% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -852.836% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1468.326% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -4374.93% |
| Apollomics, Inc. | -172.6 Million USD | -170.094% |
| Amarin Corporation plc | -59.11 Million USD | -688.647% |
| Turnstone Biologics Corp. | -55.2 Million USD | -744.538% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -217.215% |
| Synaptogenix, Inc. | -6.03 Million USD | -7620.207% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -2776.265% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -497.52% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9629.486% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -5448.371% |
| Exelixis, Inc. | 207.76 Million USD | 324.381% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1072.497% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -223.857% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 11.812% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3729.97% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -5880.802% |
| Gritstone bio, Inc. | -138.49 Million USD | -236.62% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -623.16% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -11554.771% |
| Avid Bioservices, Inc. | -140.75 Million USD | -231.208% |
| Insmed Incorporated | -749.56 Million USD | 37.806% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -2969.125% |
| MediWound Ltd. | -6.71 Million USD | -6841.409% |
| OmniAb, Inc. | -50.61 Million USD | -820.968% |
| Alector, Inc. | -130.39 Million USD | -257.529% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -309.927% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -799.155% |
| Zai Lab Limited | -334.62 Million USD | -39.318% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -43.89% |
| Aura Biosciences, Inc. | -76.4 Million USD | -510.126% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -98.688% |
| Immunic, Inc. | -93.61 Million USD | -397.997% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -243.053% |
| Veracyte, Inc. | -74.4 Million USD | -526.559% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -5973.636% |
| FibroGen, Inc. | -284.23 Million USD | -64.016% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1677.161% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6557.988% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2375.403% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1966.881% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1046.165% |
| Galecto, Inc. | -38.34 Million USD | -1115.638% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2371.033% |
| Fortrea Holdings Inc. | -3.4 Million USD | -13611.324% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -268.107% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2577.531% |
| XBiotech Inc. | -24.55 Million USD | -1798.379% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -623.16% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -643.754% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -373.64% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2075.69% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -744.645% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 23.153% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -583.005% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -105.786% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1993.565% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -112.182% |
| NexImmune, Inc. | -32.34 Million USD | -1341.316% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -8718.282% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3219.012% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 111.791% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1824.714% |
| Ainos, Inc. | -13.77 Million USD | -3285.377% |
| Pluri Inc. | -20.88 Million USD | -2131.832% |
| Prothena Corporation plc | -147.02 Million USD | -217.072% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -309.397% |
| Celularity Inc. | -196.29 Million USD | -137.492% |
| Rallybio Corporation | -74.56 Million USD | -525.215% |
| Cue Biopharma, Inc. | -50.73 Million USD | -818.899% |
| MeiraGTx Holdings plc | -84.02 Million USD | -454.804% |
| Omeros Corporation | -117.81 Million USD | -295.699% |
| Humacyte, Inc. | -110.77 Million USD | -320.836% |
| Immunocore Holdings plc | -55.28 Million USD | -743.209% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2492.221% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1932.99% |
| Blueprint Medicines Corporation | -506.98 Million USD | 8.047% |
| CalciMedica, Inc. | -34.35 Million USD | -1256.885% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -588.859% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -181.192% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -64.581% |
| Pulmatrix, Inc. | -14.12 Million USD | -3201.36% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1224.577% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -464.129% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 3.119% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -344.532% |
| Cytokinetics, Incorporated | -526.24 Million USD | 11.413% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1192.624% |
| Nutriband Inc. | -5.48 Million USD | -8398.784% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1053.352% |
| Vor Biopharma Inc. | -117.86 Million USD | -295.531% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 110.72% |
| Evogene Ltd. | -23.87 Million USD | -1852.28% |
| ProKidney Corp. | -35.46 Million USD | -1214.382% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -289.256% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 27.521% |
| CorMedix Inc. | -46.33 Million USD | -906.027% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -358.194% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1035.209% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1058.972% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -478.033% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -517.292% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -59.548% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1572.353% |
| MediciNova, Inc. | -8.57 Million USD | -5338.77% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -278.161% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5465.169% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1695.314% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -94.862% |
| Biomea Fusion, Inc. | -117.25 Million USD | -297.582% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 25.601% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1482.112% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -204.374% |
| Absci Corporation | -110.56 Million USD | -321.635% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1446.219% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -362.315% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -97.589% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3410.033% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -141.594% |
| Allakos Inc. | -185.7 Million USD | -151.041% |
| Imunon, Inc. | -19.51 Million USD | -2288.858% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -378.949% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 539.217% |
| BioAtla, Inc. | -123.46 Million USD | -277.594% |
| NLS Pharmaceutics AG | -12.17 Million USD | -3729.97% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -2799.521% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -42.449% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1161.699% |
| XOMA Corporation | -40.83 Million USD | -1041.743% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -357.627% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -293.362% |
| aTyr Pharma, Inc. | -50.38 Million USD | -825.172% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -431.695% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -207.188% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -96.095% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1227.444% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -5661.103% |
| Akari Therapeutics, Plc | -10 Million USD | -4558.124% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -692339.658% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 265.552% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -6894.63% |
| UroGen Pharma Ltd. | -102.24 Million USD | -355.953% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -336.531% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -5894.265% |
| Orgenesis Inc. | -55.36 Million USD | -742.082% |
| Entera Bio Ltd. | -8.88 Million USD | -5144.516% |
| GH Research PLC | -35.58 Million USD | -1209.987% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2136.972% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -502.4% |
| Xencor, Inc. | -126.08 Million USD | -269.733% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -12279.763% |
| Replimune Group, Inc. | -215.79 Million USD | -116.032% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2092.106% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 18680.51% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -6894.63% |
| Portage Biotech Inc. | -75.33 Million USD | -518.783% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -5465.169% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -382.319% |
| OncoCyte Corporation | -27.78 Million USD | -1578.071% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3374.53% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -4091.738% |
| Purple Biotech Ltd. | -19.88 Million USD | -2244.995% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -6541.758% |
| scPharmaceuticals Inc. | -54.81 Million USD | -750.547% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2562.98% |
| HilleVax, Inc. | -123.56 Million USD | -277.276% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -4512.496% |
| Tharimmune, Inc. | -9.31 Million USD | -4902.471% |
| Genprex, Inc. | -30.86 Million USD | -1410.622% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -97.599% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1449.096% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -26060.774% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -8702.562% |
| OKYO Pharma Limited | -16.82 Thousand USD | -2770611.767% |
| Savara Inc. | -54.69 Million USD | -752.289% |
| Curis, Inc. | -47.41 Million USD | -883.243% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1445.635% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -2918.338% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1463.592% |
| BeiGene, Ltd. | -881.7 Million USD | 47.127% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2089.279% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -6.833% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -490.444% |
| Erasca, Inc. | -125.04 Million USD | -272.823% |
| bluebird bio, Inc. | -211.91 Million USD | -119.989% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -9222.773% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 378.079% |
| DBV Technologies S.A. | -72.72 Million USD | -541.016% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -9222.773% |
| Moderna, Inc. | -4.71 Billion USD | 90.111% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1060.906% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -8087.302% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -671.983% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -318.482% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -244.424% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -872.86% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -229.625% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -142.287% |
| MacroGenics, Inc. | -9.05 Million USD | -5046.666% |
| RenovoRx, Inc. | -10.23 Million USD | -4456.147% |
| Adicet Bio, Inc. | -142.65 Million USD | -226.785% |
| Prime Medicine, Inc. | -198.13 Million USD | -135.289% |
| Aditxt, Inc. | -32.38 Million USD | -1339.694% |
| Adagene Inc. | -18.94 Million USD | -2360.55% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6275.857% |
| Quantum-Si incorporated | -95.96 Million USD | -385.812% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -291.657% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3097.918% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 452.29% |
| SciSparc Ltd. | -5.12 Million USD | -9001.62% |
| Vericel Corporation | -3.18 Million USD | -14550.691% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -387566.938% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1453.673% |
| Generation Bio Co. | -126.61 Million USD | -268.2% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -539.565% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -465.47% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -77.838% |
| Invivyd, Inc. | -198.64 Million USD | -134.685% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -36.322% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -5266.731% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2144.133% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -4621.339% |
| 2seventy bio, Inc. | -217.57 Million USD | -114.269% |
| Clene Inc. | -49.5 Million USD | -841.712% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1991.684% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -843.045% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1695.314% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -42.101% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1332.524% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2151.871% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -371.887% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -523.625% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -189.907% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 24.205% |
| Evaxion Biotech A/S | -22.12 Million USD | -2007.051% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -477.419% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -133.013% |
| Trevena, Inc. | -40.28 Million USD | -1057.102% |
| Surrozen, Inc. | -43.04 Million USD | -983.093% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -574.321% |
| Cingulate Inc. | -23.53 Million USD | -1880.82% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -6644.575% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1069.556% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -5945.97% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -416.778% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -660.671% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -683.465% |
| Clearmind Medicine Inc. | -11.95 Million USD | -3799.488% |
| Kronos Bio, Inc. | -112.67 Million USD | -313.75% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -573.707% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -18380922.226% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -442.738% |
| Statera Biopharma, Inc. | -174.4 Million USD | -167.295% |
| ImmunityBio, Inc. | -583.19 Million USD | 20.064% |
| Korro Bio, Inc. | -81.17 Million USD | -474.317% |
| Kineta, Inc. | -14.09 Million USD | -3206.511% |
| BioVie Inc. | -32.12 Million USD | -1351.361% |
| Codexis, Inc. | -76.24 Million USD | -511.47% |
| Celularity Inc. | -196.29 Million USD | -137.492% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -117.306% |
| Celcuity Inc. | -63.77 Million USD | -630.937% |
| Virax Biolabs Group Limited | -6.73 Million USD | -6823.33% |
| Cibus, Inc. | -267.62 Million USD | -74.192% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1056.041% |
| IN8bio, Inc. | -30 Million USD | -1453.587% |
| Kodiak Sciences Inc. | -260.49 Million USD | -78.964% |
| Annexon, Inc. | -134.23 Million USD | -247.285% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -297.888% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -661.392% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1377.888% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -27.273% |
| Eyenovia, Inc. | -27.26 Million USD | -1610.074% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2259.164% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -87037.383% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -510.158% |
| Arcellx, Inc. | -70.69 Million USD | -559.478% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1024.937% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -248.378% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1452.036% |
| Moolec Science SA | -51.78 Million USD | -800.164% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -790.159% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1010.652% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -242.894% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -5142.862% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2094.511% |
| Humacyte, Inc. | -110.77 Million USD | -320.836% |
| 89bio, Inc. | -142.18 Million USD | -227.863% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -576.022% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -4392.483% |
| Genelux Corporation | -28.29 Million USD | -1547.471% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1503.939% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -163.204% |
| Notable Labs, Ltd. | -11.26 Million USD | -4038.716% |
| Liquidia Corporation | -78.5 Million USD | -493.851% |
| Mustang Bio, Inc. | -51.6 Million USD | -803.424% |
| Immunovant, Inc. | -259.33 Million USD | -79.761% |
| Quantum-Si incorporated | -95.96 Million USD | -385.812% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -539.933% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2305.371% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -385.66% |
| Acasti Pharma Inc. | -12.85 Million USD | -3527.052% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1975.821% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -2820.655% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -155.594% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -10737.688% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -3638.452% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1480.77% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1095.714% |
| PepGen Inc. | -78.62 Million USD | -492.915% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1466.008% |
| United Therapeutics Corporation | 984.8 Million USD | 147.338% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1994.272% |
| Solid Biosciences Inc. | -96.01 Million USD | -385.534% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9629.486% |
| Immuneering Corporation | -53.47 Million USD | -771.836% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -9064.19% |
| Silo Pharma, Inc. | -3.7 Million USD | -12497.269% |
| Belite Bio, Inc | -31.63 Million USD | -1373.777% |
| XOMA Corporation | -40.83 Million USD | -1041.743% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -757.509% |
| Bionomics Limited | -15.49 Billion USD | 96.991% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -455.081% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1498.878% |
| uniQure N.V. | -308.47 Million USD | -51.124% |
| Cassava Sciences, Inc. | -97.21 Million USD | -379.53% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6275.857% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -277.692% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1381.081% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -5584.002% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1503.774% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -87037.383% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1677.161% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -2727.934% |
| Altimmune, Inc. | -88.44 Million USD | -427.078% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -207.542% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1498.878% |
| Compugen Ltd. | -18.75 Million USD | -2385.79% |
| Peak Bio, Inc. | -1259.26 USD | -37020451.753% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -912.367% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2043.281% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -37.603% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -461.98% |
| Zura Bio Limited | -60.36 Million USD | -672.341% |
| PolyPid Ltd. | -23.86 Million USD | -1853.426% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -2863.291% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -461.98% |
| Instil Bio, Inc. | -156.08 Million USD | -198.67% |
| argenx SE | -295.05 Million USD | -58.0% |
| Immunome, Inc. | -106.8 Million USD | -336.478% |
| Verona Pharma plc | -54.36 Million USD | -757.446% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -366.572% |
| Shattuck Labs, Inc. | -87.29 Million USD | -434.016% |
| CervoMed Inc. | -2.17 Million USD | -21364.653% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -273.992% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3400.939% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -970.336% |
| Moolec Science SA | -51.78 Million USD | -800.164% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -2695899.764% |
| Design Therapeutics, Inc. | -66.86 Million USD | -597.235% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -472.61% |
| NeurAxis, Inc. | -14.62 Million USD | -3087.223% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1130.624% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1269.763% |
| Achilles Therapeutics plc | -69.66 Million USD | -569.181% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -366.572% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2238.512% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 15594.102% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -18380922.226% |
| Nutriband Inc. | -5.48 Million USD | -8398.784% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -362.958% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -859.09% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -504.72% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1272.343% |
| MoonLake Immunotherapeutics | -36 Million USD | -1194.697% |
| Palisade Bio, Inc. | -12.3 Million USD | -3690.122% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1006.697% |
| Beam Therapeutics Inc. | -132.52 Million USD | -251.766% |
| Neurogene Inc. | -36.31 Million USD | -1183.655% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -185.277% |
| AEON Biopharma, Inc. | -52.55 Million USD | -787.025% |
| Sesen Bio, Inc. | -19.88 Million USD | -2244.523% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -551.242% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -3625.339% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -4.988% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -317.856% |
| Athira Pharma, Inc. | -117.67 Million USD | -296.173% |
| Vaccinex, Inc. | -20.25 Million USD | -2202.034% |
| HCW Biologics Inc. | -24.99 Million USD | -1765.167% |
| XOMA Corporation | -40.83 Million USD | -1041.743% |
| Nektar Therapeutics | -276.05 Million USD | -68.873% |
| Arvinas, Inc. | -367.3 Million USD | -26.922% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -692339.658% |
| Merus N.V. | -154.93 Million USD | -200.883% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -378.492% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1385.375% |
| Rezolute, Inc. | -68.45 Million USD | -580.97% |
| Clene Inc. | -49.5 Million USD | -841.712% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2922.569% |
| BeyondSpring Inc. | -21.02 Million USD | -2117.183% |
| Synlogic, Inc. | -57.28 Million USD | -713.842% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -3817.192% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4206.161% |
| Peak Bio, Inc. | -1259.26 USD | -37020451.753% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1147.551% |
| Krystal Biotech, Inc. | 10.93 Million USD | 4364.407% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -225.778% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -43.396% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -9992.845% |
| MannKind Corporation | -11.93 Million USD | -3805.051% |
| Ikena Oncology, Inc. | -68.16 Million USD | -583.897% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2118.344% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -401.636% |
| Gossamer Bio, Inc. | -179.81 Million USD | -159.255% |
| CohBar, Inc. | -11.96 Million USD | -3797.177% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1707.759% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1446.219% |
| Legend Biotech Corporation | -518.25 Million USD | 10.047% |
| Mural Oncology plc | -207.44 Million USD | -124.725% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -275.607% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2448.89% |
| Disc Medicine, Inc. | -76.42 Million USD | -509.958% |
| Champions Oncology, Inc. | -7.27 Million USD | -6307.161% |
| REGENXBIO Inc. | -263.49 Million USD | -76.924% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -4292.554% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -881.339% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1127.336% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -365.426% |
| Vaxart, Inc. | -82.46 Million USD | -465.313% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 139775.458% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1141.752% |
| Cellectis S.A. | -101.05 Million USD | -361.3% |
| Longeveron Inc. | -21.41 Million USD | -2077.112% |
| Repare Therapeutics Inc. | -93.79 Million USD | -397.02% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 13.021% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -555.039% |
| Revolution Medicines, Inc. | -436.36 Million USD | -6.833% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -6994.582% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1412.409% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -572.385% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -620.177% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -4651.656% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 112.879% |
| Denali Therapeutics Inc. | -145.22 Million USD | -221.011% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -387566.938% |
| Veru Inc. | -93.15 Million USD | -400.453% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1624.759% |
| Cingulate Inc. | -23.53 Million USD | -1880.82% |
| Passage Bio, Inc. | -102.06 Million USD | -356.766% |
| Context Therapeutics Inc. | -23.96 Million USD | -1845.338% |
| Exicure, Inc. | -16.91 Million USD | -2656.208% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -146.767% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1134.469% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -7064.004% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -152.431% |
| Nuvalent, Inc. | -126.21 Million USD | -269.346% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -4333.247% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -436.591% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1426.274% |
| OmniAb, Inc. | -50.61 Million USD | -820.968% |
| Anew Medical, Inc. | 1.34 Million USD | 34731.628% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -2805.485% |
| Lipocine Inc. | -16.35 Million USD | -2750.921% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -602.149% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -632.132% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1004.866% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -871.887% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2250.789% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 13.907% |
| Ocugen, Inc. | -63.07 Million USD | -639.061% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -386.969% |
| Q32 Bio Inc. | -112.96 Million USD | -312.696% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -2611.639% |
| Alumis Inc. Common Stock | -154.99 Million USD | -200.778% |
| Equillium, Inc. | -13.33 Million USD | -3395.951% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -672.264% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -5736.186% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2372.969% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -689.047% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -307.052% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2436.653% |
| Dominari Holdings Inc. | -22.88 Million USD | -1937.344% |
| Edesa Biotech, Inc. | -8.37 Million USD | -5466.777% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2202.148% |
| Bio-Techne Corporation | 168.1 Million USD | 377.318% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -32.406% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 461.796% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -282.646% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1128.775% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -313.864% |
| Nkarta, Inc. | -117.5 Million USD | -296.75% |
| BioCardia, Inc. | -11.57 Million USD | -3928.908% |
| Iterum Therapeutics plc | -38.37 Million USD | -1114.941% |